0000899243-20-017886.txt : 20200630 0000899243-20-017886.hdr.sgml : 20200630 20200630064930 ACCESSION NUMBER: 0000899243-20-017886 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200625 FILED AS OF DATE: 20200630 DATE AS OF CHANGE: 20200630 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GANNON STEVEN CENTRAL INDEX KEY: 0001643085 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39344 FILM NUMBER: 201000384 MAIL ADDRESS: STREET 1: C/O XENON PHARMACEUTICALS INC. STREET 2: 200 - 3650 GILMORE WAY CITY: BURNABY STATE: A0 ZIP: V5G 4W8 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Fusion Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001805890 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: Z4 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 BUSINESS PHONE: 289-799-0891 MAIL ADDRESS: STREET 1: 270 LONGWOOD ROAD SOUTH CITY: HAMILTON STATE: A6 ZIP: L8P 0A6 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2020-06-25 0 0001805890 Fusion Pharmaceuticals Inc. FUSN 0001643085 GANNON STEVEN C/O FUSION PHARMACEUTICALS INC. 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 ONTARIO, CANADA 1 0 0 0 Stock Option (Right to Buy) 2.35 2020-01-19 4 A 0 141011 0.00 A 2030-01-19 Non-Voting Common Shares 141011 141011 D Stock Option (Right to Buy) 17.00 2020-06-25 4 A 0 30000 0.00 A 2030-06-18 Common Shares 30000 30000 D This option shall vest and become exercisable in 36 equal monthly installments beginning on February 19, 2020. Prior to closing of the Issuer's initial public offering, such Non-Voting Common Shares will convert into Voting Common Shares and subsequently into Common Shares on a one-for-one basis. This option shall vest and become exercisable in 36 equal monthly installments beginning on July 18, 2020. /s/ John Crowley, Attorney-in-Fact 2020-06-29